Medical devices and euromedlab biocidal products


Clinical research plays a key role in the development of medicine and pharmacy. They allow to increase medical knowledge among doctors, but euromedlab above all they give a chance for effective and safe treatment of patients. $ 40,000. Every year poles decide to participate in clinical trials.

Over the past 20 years euromedlab

Every year around the world, tens of thousands of clinical trials are launched, involving about 100,000 people. 1 million patients. Over the past 20 years, scientists have discovered and developed more than 300 new drugs euromedlab, vaccines and medical products that have been marketed and are effective in more than 150 diseases.

In clinical trials euromedlab, patient safety is paramount, which is ensured by the application of the principles of good clinical practice (GCP).

Each study must be approved by an independent bioethical commission consisting of several dozen people-doctors, nurses, a lawyer and an ethicist-before it can begin. The commission shall assess the safety and appropriateness of the test. Every study in Poland must obtain the approval of the minister of health-at the request of the office for registration of medicinal products, medical devices and biocidal products. They can only be started and continued if the expected benefits to the patient outweigh the potential risks.